K. Stralen

发表

Demographics of CKD and ESRD in Children

J. Craig, J. Harambat, K. Stralen, 2016 .

Lessons learned from the ESPN/ERA–EDTA Registry

F. Schaefer, J. Groothoff, K. Jager, 2016, Pediatric Nephrology.

Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA–EDTA registry

A. Jankauskienė, F. Schaefer, J. Groothoff, 2014, Pediatric Nephrology.

Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN-ERA/EDTA registry analysis

F. Schaefer, J. Groothoff, K. Jager, 2017, The Lancet.

UvA-DARE ( Digital Academic Repository ) Experience with multiple control groups in a large population-based case-control study on genetic and environmental risk factors

S. Cessie, F. Rosendaal, J. Vandenbroucke, 2010 .

Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS 1

F. Schaefer, J. Groothoff, K. Jager, 2022 .

Glomerular fi ltration rate-estimating equations for patients with advanced chronic kidney disease

M. Evans, M. Stendahl, K. Jager, 2013 .

Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA Registry

F. Caskey, J. Groothoff, R. Topaloğlu, 2014 .

Anemia in children following renal transplantation—results from the ESPN/ERA-EDTA Registry

A. Jankauskienė, F. Schaefer, K. Jager, 2016, Pediatric Nephrology.

Likelihood of children with end-stage kidney disease in Europe to live with a functioning kidney transplant is mainly explained by nonmedical factors

F. Schaefer, J. Groothoff, K. Jager, 2014, Pediatric Nephrology.

How much of the regional variation in RRT incidence rates within the UK is explained by the health needs of the general population?

F. Schaefer, J. Groothoff, K. Jager, 2012 .

Typical RSV cough: myth or reality? A diagnostic accuracy study

K. Stralen, M. Houten, Mirjam Binnekamp, 2020, European Journal of Pediatrics.

MP826THE ASSOCIATION OF DONOR AND RECIPIENT AGE WITH GRAFT SURVIVAL IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS AN ESPN/ERA-EDTA REGISTRY STUDY

B. Tönshoff, F. Schaefer, J. Groothoff, 2017 .

Effects of initiating chronic renal replacement therapy in children, now and later in life: Data from the LERIC cohort and ERA-EDTA Registry

K. Jager, K. Stralen, J. Vogelzang, 2015 .

SuO033EXPLORING THE DIFFERENTIAL MORTALITY RISK IN EUROPEAN CHILDREN WITH END-STAGE RENAL DISEASE - RESULTS FROM THE ESPN/ERA-EDTA REGISTRY

F. Schaefer, J. Groothoff, K. Jager, 2015 .

Risk factors for QTc interval prolongation

P. Bemt, A. Mantel‐Teeuwisse, M. Becker, 2018, European Journal of Clinical Pharmacology.

HMG‐CoA reductase inhibitors, other lipid‐lowering medication, antiplatelet therapy, and the risk of venous thrombosis

F. Rosendaal, A. Mantel‐Teeuwisse, K. Stralen, 2009, Journal of thrombosis and haemostasis : JTH.

Gender Disparities in Access to Pediatric Renal Transplantation in Europe: Data From the ESPN/ERA‐EDTA Registry

F. Schaefer, J. Groothoff, K. Jager, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients

C. Wanner, F. Rosendaal, P. Ravani, 2012, Journal of thrombosis and haemostasis : JTH.

Disparities in Policies, Practices and Rates of Pediatric Kidney Transplantation in Europe

B. Tönshoff, A. Jankauskienė, F. Schaefer, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

HMG‐CoA reductase inhibitors, other lipid‐lowering medication, antiplatelet therapy, and the risk of venous thrombosis

F. Rosendaal, A. Mantel‐Teeuwisse, K. Stralen, 2009, Journal of thrombosis and haemostasis : JTH.

Risk factors for QTc interval prolongation

P. Bemt, A. Mantel‐Teeuwisse, M. Becker, 2017, European Journal of Clinical Pharmacology.

Prevalence and predictors of the sub-target Hb level in children on dialysis.

F. Schaefer, J. Groothoff, K. Jager, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Determinants of eGFR at start of renal replacement therapy in paediatric patients.

A. Jankauskienė, F. Schaefer, J. Groothoff, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA–EDTA registry

A. Jankauskienė, F. Schaefer, J. Groothoff, 2014, Pediatric Nephrology.

Demographics of paediatric renal replacement therapy in Europe: 2007 annual report of the ESPN/ERA-EDTA registry

F. Schaefer, K. Jager, E. Verrina, 2010, Pediatric Nephrology.

Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry.

G. Ariceta, F. Schaefer, J. Groothoff, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.